Search results

Press Release

Hoth Therapeutics Announces the Selection of Altasciences for Manufacturing HT-TBI for Traumatic Brain Injury and Stroke

Sep 20, 2022

Scientific Publication

Case Study― Assess the Safety, Tolerability, and Pharmacokinetics of Ascending Doses of Palovarotene (POS)

Sep 12, 2022

• Clinical Trials

Blog

Up Close and Personal With Marie-Hélène Raigneau, MBA, Co-Chief Operating Officer

Jul 25, 2022

• About Altasciences

ISSUE NO. 25 — Flexibility in Phase I Study Timing

Jul 15, 2022

ISSUE NO. 24 — Shortening Drug Development Timelines with Asian Ethnobridging Trials

Jun 27, 2022

Scientific Publication

Key Biomarkers of Immunomodulation: Complement Factors and Cytokines

Jun 17, 2022

• Bioanalysis
• Outsourcing Drug Development

ISSUE NO. 23 — Robust Sample Management for Reliable Study Results

May 30, 2022